adsilico
Virtual patient populations for testing implantable medical devices
Community-submitted · content unverified. This organization has not verified ownership or the information in this profile.
About
adsilico is a University of Leeds spinout, founded in 2024, that helps medical device makers see how implantable devices perform across diverse patient populations. Its Virtual Chimera technology uses generative AI to build fully synthetic virtual hearts and blood vessels from anonymised clinical imaging, then runs physics-based simulations of devices such as heart valves and stents across virtual populations varying in age, sex, ethnicity, anatomy and disease. In October 2026 it announced a £10M Series A led by PXN Ventures with Northern Gritstone and Parkwalk.
- Website
- adsilico.uk
- Added via
- web
- Ownership
- unclaimed
Where to go
For people
- Homepageadsilico.uk
For agents
Nothing listed yet.